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The choice of proper excipients is one of the key factors for successful formulation of 
pharmaceutical dosage forms. Increasing number of new therapeutic compounds suffers 
from poor solubility and/or bioavailability, creating a challenge from the drug formulation 
point of view. Problems have also been encountered in attempts to formulate biological 
drugs such as peptides and proteins, considering their sensitivity towards certain 
production  processes  and  routes  of  administration.  In  both  cases  the  choice  of  the  right  
excipient(s) is essential to provide particular processability and development of systems 
with desirable drug delivery kinetics.  
The aim of this work was to evaluate pharmaceutical applications of nanofibrillar 
cellulose (NFC), a renewable, biodegradable and widely available plant based material, as 
a potential excipient in the production of pharmaceutical dosage forms. 
Initially, tablets with immediate drug release were manufactured by methods of direct 
compression and compression after wet granulation using spray dried NFC as a filler 
material. Addition of NFC improved the flow properties of commercially available and 
widely used microcrystalline cellulose.  
The main focus of the thesis was to evaluate NFC material for long-term sustained 
drug release purposes. This goal was successfully achieved by two approaches: 1) by 
setting up a spray drying method for the production of drug loaded NFC microparticles, 
and 2) by developing a simple three-step method for the production of drug loaded NFC 
films with matrix structures. Both systems were able to sustain the drug release over long 
periods of time ranging from two months for the spray dried microparticles up to over 
three months for the films. The drug release kinetics were system and drug dependent, 
reaching, in several cases, zero order drug release kinetics. 
The final part of the thesis work focused on studying the interactions between small 
molecular weight drugs, peptides and proteins with the NFC fibers. The purpose of this 
study was to further clarify and fully understand the mechanisms behind the successful 
performance of NFC as drug release controlling material. Binding of drugs to NFC due to 
the electrostatic interactions was observed. This kind of knowledge is beneficial when 
choosing the proper drug/excipient combination for the formulation process. 
In conclusion, NFC was shown to be a versatile excipient for the production of 
pharmaceutical dosage forms, while the comprehensive evaluation of the full potential of 
NFC in pharmaceutical applications warrants further experiments in the future. 
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1 Introduction 
European Pharmacopoeia defines an excipient (auxiliary substance) as any constituent 
of a medicinal product that is not an active substance. Pharmaceutical excipients have vital 
roles in drug formulations and dosage forms.  
Recent trends in drug discovery are leading towards new chemical entities with high 
molecular weight and increased lipophilicity [1]. Thus, an increasing number of drug 
candidates suffers from low aqueous solubility and, therefore, requires specialized 
formulations in order to fulfill their potential. On the other hand biological drugs, such as 
peptides, proteins and monoclonal antibodies, often possess poor membrane permeability, 
enzymatic instability, large molecular size and hydrophilic properties, which represent 
significant challenges for the choice of right excipients for successful formulations. 
Besides facing the challenges seen in new drug candidates, pharmaceutical industry strives 
to improve manufacturing processes, reduce costs and improve the performance of 
existing products by employing proper excipients.  
In the area of production of immediate release tablets, direct compression is preferred 
manufacturing process, in order to improve the manufacturing costs and productivity [2, 
3]. Direct compression requires excipients with certain physical characteristics in terms of 
flowability and compressibility. Thus, the ideal excipient would provide excellent 
compactibility at low pressures, have a high dilution potential, improve the flowability of 
powder blend and, at the same time have low price. 
Simultaneously, drug manufacturers are aiming towards excipients to improve the 
performance of controlled release formulations, which enable faster development and easy 
manufacturing. Here the specific focus exist in the development of long-lasting sustained 
release systems, where difficulties rise when they are administered by implantation 
considering high requirements in terms of sterility, biocompatibility, physical and 
mechanical properties and  also desirable drug delivery profile.  
All mentioned challenges explain the constant demand in pharmaceutical industry for 
development of novel excipients. 
Cellulose and its corresponding neutral, acidic and basic derivatives have a long 
history as pharmaceutical excipients in various types of formulations [4]. Recently, 
microscopic cellulose fibers of plant origin have been disintegrated to the level of 
nanoscale fibers and the material has been termed nanofibrillar cellulose (NFC). The 
material has found application in various research areas due to its excellent mechanical 
properties. When it comes to pharmaceutical application, NFC has been recognized as 
material for modification of rheological properties [5], stabilization of nanosuspensions 
[6] as well as formation of nanoparticles embedded aerogels [7].    
This thesis work focused on evaluation of NFC as a novel versatile excipient for the 
formulation of pharmaceutical dosage forms. Our aim was to investigate applicability of 
NFC in formulation of different dosage forms ranging from immediate towards controlled 
drug release systems.  
Initial hypothesis was that spray dried NFC could be used as filler in production of 
tablets with imnmediate release. Fillers for tablet production have to fulfill certain criteria 
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in terms of powder characteristics. Therefore our aim was to characterize spray dried NFC 
in terms of powder properties (e.g. bulk, tapped and true density, flow properties) and 
compare it to two grades of commercially available and widely used microcrystalline 
cellulose. Furhter we aimed at manufacturing the tablets with immediate drug release by 
methods of direct compression and compression after wet granulation using spray dried 
NFC as a filler material. 
The  main  goal  of  the  thesis  was  to  test  the  applicability  of  NFC as  excipient  for  the  
production of controlled drug release systems, which would provide release of a drug over 
time period of up to three months or longer. In order to achieve this goal two different 
types of drug delivery sytems were to be produced and tested. First, the spray dried 
microparticles which would provide prolonged drug release of drugs soluble in aqueous 
solvents and second, drug loaded thin films produced by filtration method, which would 
be suitable for sustained release of water insoluble compounds. In both cases, 
microparticles and films, systems would have matrix structure with NFC fibers being 
matrix  former.  Thus,  the  concept  that  NFC can  be  successfully  used  as  an  excipient  for  
controlled drug delivery systems could be proven.  
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2 Review of the literature 
2.1 Cellulose 
Biopolymers (such as cellulose and its derivatives, starch, chitosan, etc.) are often used 
and studied as pharmaceutical excipients due to their availability, low toxicity, 
biodegradability and renewable nature. Among all biopolymers used in formulation of 
drug delivery systems, cellulose and its derivatives are the most widely used ones. Main 
sources for cellulose isolation are plant-based materials such as wood, cotton, and straw. 
In plants cellulose is constituent of the cell wall and it has a reinforcing role [8]. Besides 
plants,  it  is  also  synthesized  by  some  bacterial  species  (Gluconacetobacter xylinus) [9], 
algae (Oocystis apiculata) [10], and tunicates (Microcosmus fulcatus) [11].  
Understanding of the cellulose organization within plants is necessary for successful 
understanding of the properties and production processes of NFC. The same phenomena 
will affect their self-assembly and organization in manufactured products. 
2.1.1 Cellulose supermolecular structure 
Anselme Payen discovered and isolated cellulose from green plants in 1838 and 
suggested that cell walls of almost any plant are constructed of the same substance [12]. 
However, it was only in the 20th century that the structure of cellulose was resolved [13, 
14]. Cellulose is composed of linear chains formed of ? (1?4) linked D-glucopyranosyl 
units. Every second anhydrose glucose unit (AGU) is rotated 180° in the plane to facilitate 
preferred angle for creation of acetal bond between two neighboring glucopyranosyl rings. 
Thus, the two neighboring residues form the structural unit called cellobiose (Figure 1) 
[8].  
 
Figure 1 The structure of cellulose. Two cellulose monomers (anhydroglucose units) build 
dimer (cellobiose). 
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The length of the cellulose chains (degree of polymerization, DP) varies greatly 
depending on the material source and could be in the range of 300-10000 [15], although 
already 20-30 AGUs give the material properties of cellulose [16]. Each glucose unit 
possesses three hydroxylic groups, two primary groups at the positions C2 and C3, and 
one secondary at the position C6. These hydroxylic groups are able to establish intra and 
intermolecular hydrogen bonds, thereby forming crystalline structures. Based on the 
molecular orientation and hydrogen bonding pattern, four different polymorphs of 
cellulose (and their allomorphs) have been identified: I, II, III and IV [17, 18]. Forms I and 
II are the most studied ones and the difference in their structure is shown in the Figure 2. 
The dominant hydrogen bond for cellulose I is the O6-H---O3, whereas for cellulose II it 
is the O6-H---O2. Furthermore, the chains in cellulose I are organized in parallel direction, 
whereas  cellulose  II  has  an  antiparallel  packing.  Native  cellulose  from  plant  sources  
occurs in form I with two allomorphs I? and I? [19], and their ratio depends on the 
material source. I? is a metastable form and it consists of triclinic unit cells, while I? 
allomorph (which is predominant in higher plants) exhibits a monoclinic type of unit cells. 
Cellulose II is rarely found in the nature, but it can be obtained from cellulose I by 
regeneration or mercerization processes. Regeneration includes solubilization of cellulose 
I in a solvent, while mercerization involves only swelling of cellulose in sodium 
hydroxide. Both processes end by a reprecipitation step, in which the more 
thermodynamically stable cellulose II form is obtained. Cellulose forms III and IV are 
formed from cellulose I and II via different chemical procedures [20-22].  
 
Figure 2 Major supramolecular difference between cellulose I and cellulose II. 
During the process of wood biosynthesis, the cellulose chains are synthetized in a 
parallel fashion, which leads to hydrogen bonding between the neighboring chains. In 
native cellulose 30-40 glucan chains are assembled and merged into a single microfibril, 
denoted as elementary fibril. These microfibrils are not completely crystalline, but they 
show less ordered, amorphous regions, creating an irregular pattern of amorphous and 
crystalline domains. These elementary fibrils have been shown to be 2.5-4 nm in diameter 
and up to a few micrometers in length. The elementary fibrils are then aggregated to form 
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bundles with diameters in a range of 10-20 nm and further microscopic cellulose fibers. 
The scheme of cellulose hierarchical organization is shown in Figure 3. In the wood 
cellulose the microfibrils are surrounded by an amorphous matrix of hemicelluloses and 
lignin.  
 
Figure 3 Schematic drawing of cellulose organization in cell walls of plants showing its 
hierarchical structure (This picture was provided by Dr. Antti Laukkanen from the UPM 
company). The existence of amorphous and crystalline regions is shown in lateral fiber structure. 
2.1.2 Hemicelluloses 
In  the  plant  cell  wall  of  wood  fibers  the  cellulose  microfibrils  are  surrounded  by  an  
amorphous matrix of lignin and hemicellulose. Lignins are water insoluble amorphous 
polymers of phenylpropane units, which are removed during the pulp preparation. The 
lignin matrix is crosslinked with the cellulose fibrils by hemicellulose. In contrast to 
cellulose, the hemicelluloses are heteropolysaccharides, with their monomeric components 
consisting of anhydrohexoses. In hardwood, the major hemicellulose component is O-
acetyl-4-O-methylglucurono-?-D-xylan (Figure 4), sometimes called glucuronoxylan. 
Depending on the hardwood species, the xylan content varies within 15-30% w/w of the 
dry wood. The backbone consists of ? (1?4) linked D-xylopyranose units. About seven of 
ten  xylose  units  contain  an  O-acetyl  group  at  the  C2  or  C3.  In  addition,  per  ten  xylose  
units there is on average one (1?2) linked 4-Omethyl-?-D-glucuronic acid residue. 
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Figure 4 Principal structure of glucuronoxlyan  
2.2 Nanofibrillar cellulose (NFC) 
The structure of native cellulosic fibers results in two families of nanocellulose 
materials. Since the cellulose microfibrils consist of both amorphous and crystalline 
regions, treatment of them in strongly acidic conditions leads to an extensive hydrolysis of 
the amorphous fractions and formation of short rod-like cellulose nanowhiskers with high 
crystallinity and low aspect ratio (Figure 5). The diameter of these whiskers is typically 
around 2-20 nm, while they have wide length distribution of 100-600 nm. Several terms 
are used in the literature to denote the whiskers, nanowhiskers [23-25], nanorods [26, 27], 
and rod-like cellulose crystals [28]. When the macroscopic cellulose fibers are 
mechanically disintegrated avoiding the strongly acidic conditions, long nanoscale partly 
amorphous fibrils are produced (Figure 5). In the literature terms such as cellulose 
nanofibers [29-33], cellulose nanofibrils [32, 33], microfibrillated cellulose [34, 35], 
nanocellulose fibers/fibrils [36, 37], or nanofibrillated cellulose [38-40] have been used to 
describe these fibers. This thesis defines nanofibrillar cellulose as elementary fibrils and 
fibril bundles with a very high aspect ratio, which have diameters in nanometer scale and 
lengths of up to several micrometers.  
In the experimental part of the thesis short- and long-term drug delivery applications of 
the NFC were explored. Thus, the contents of the following literature review chapters 
focus more on the production, properties and selected application fields of NFC, excluding 
the nanofibrillar whiskers. 
 
 
 
 
 
 
 
 
 
 
 
  Literature review 
 
 
 
7 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Three methods to disintegrate 
macroscopic cellulose fibers into micro- or 
nanoscale fibers or crystals [5]. 
 
 
2.2.1 Production of NFC 
Wood is the most commonly used source for NFC production. As explained above, 
cellulose possesses high level of organization within plant based materials, where 
nanoscale fibers are grouped and bound by hydrogen bonding to form macroscopic 
structures.  To  isolate  NFC  from  wood,  one  has  to  break  down  its  highly  organized  
hierarchical structure. The first successful attempt to isolate NFC was reported in 1983 
[41, 42]. Turbak and coworkers used multiple passing of softwood pulp through a 
laboratory homogenizer to produce the material, which they named microfibrillated 
cellulose. This method produced fibers with 10-100 nm in diameter [42]. Even though the 
authors were aware of the material’s potential at the time, immediate applications were not 
found due to the high energy consumption of the production method. NFC started getting 
full attention at the beginning of the 21st century when a series of cost-effective methods 
for its production from various plant sources was reported [43]. These methods utilize 
mechanical fibrillation using various devices, which is often combined with chemical or 
enzymathical pretreatment. The most commonly used techniques for mechanical treatment 
involve refining and high-pressure homogenization [5, 44-49], cryocrushing [50-53], and 
grinding [28, 29, 48, 54]. The main drawback of the mechanical disintegration techniques 
is high energy consumption, which can be as high as 70000 kWh/tonne [55]. To decrease 
the energy consumption, mechanical disintegration is preceded by certain pre-treatments, 
which can be alkaline [52, 53, 56, 57], oxidation (most commonly 2,2,6,6-
tetramethylpiperidine-1-oxyl radical - mediated oxidation or so called TEMPO oxidation) 
[58-62] or enzymatic [5, 63-65] pre-treatment. NFC is nowadays available product from 
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various companies and research institutes (UPM, Finland; Rettenmaier & Söhne, 
Germany; Daicel, Japan; Innventia, Sweden). 
Wood is undoubtedly the biggest source of cellulose for NFC production. However, 
non-wood plants such as corn, wheat, rice, sorghum, barley, sugar cane, pineapple, 
bananas and potato, and especially their by-products, can be valuable sources of natural 
fibers. Non-wood plants generally contain less lignin than wood and, therefore, the 
bleaching processes are less demanding [43]. Also cellulose microfibrils are less tightly 
bound in the primary cell wall in these plants than in the secondary wall in wood, thus 
fibrillation to produce NFC should be less energy demanding [66]. Further by-products of 
these plants are normally burned or used for production of low-value animal food. Thus, 
their usage as a source for NFC production is desirable from an environmental point of 
view. So far the production of NFC from soy hulls and wheat straw [50], sugar beet pulp 
[56, 61, 66], potato pulp [49], swede root [67], bagasse [68], sisal [69], cladodes of cacti 
[70], pear fruit [71], banana rachis [72], carrot [73], and bamboo [74] has been reported. 
Production processes of NFC include steps, which purpose is to remove the 
accompanying materials (e.g. lignin). However, the final material contains certain amounts 
of hemicellulose residues and their contents can vary highly depending on the material 
origin and production method [75]. The presence of hemicelluloses, which carry 
carboxylic  groups,  causes  a  slight  negative  charge  for  the  NFC.  The  negative  charge  
causes repulsion between fibers preventing in this way their aggregation in wet state [76]. 
Thus, the presence of hemicellulose promotes dispersion of otherwise non-dispersible 
NFC fibers in an aqueous medium.  
NFC used in the experimental work of this thesis was produced using bleached birch 
pulp as a starting material and a controlled homogenization process using an industrial 
fluidizer. A more detailed description of the material production is given later in the 
materials section.  
2.2.2 Properties of NFC  
2.2.2.1 Morphology 
Depending on the source of the raw material, the initial cellulose fibers used for NFC 
production can have different properties - lengths, microfibril angles, and amounts of 
residual lignin and hemicelluloses, or even other characteristics, when they come from the 
sources originally denoted as waste. These different qualities followed by different 
production methods result in NFC materials with similar morphologies, but different 
characteristics in terms of dimensions (diameter and length) and hemicellulose content. 
Table  1  lists  diameters  of  the  NFC  fibers  depending  on  the  type  of  the  mechanical  
treatment and pre-treatment used for production using the wood as starting material. 
However, it is difficult to accurately compare fiber dimensions since the raw materials are 
different.  In  general,  it  seems  that  the  application  of  pre-treatment  step  results  in  more  
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narrow size distribution and can also produce fibers with diameters as low as 3-5 nm [58, 
77]. These very low values are also due to the centrifugation step used after the fibrillation 
process, which eliminates the larger NFC fibers.  
Table 1. Diameter of the NFC fibers produced from wood sources applying different 
mechanical treatments and pre-treatments. 
Mechanical 
treatment Pre-treatment Diameter (nm) Reference 
Homogenizer  20-40 [78, 79] 
Grinder  15-50 [28, 29] 
Blender  15-20 [80] TEMPO oxidation 3-5 [58, 77] 
Microfluidizer 
 10-30 [81] 
carboxymethylation 10-15 [81] 
enzymatic 20-30 [5] 
 
NFC  fibers  extracted  from  plant  sources  other  than  wood  can  have  higher  or  lower  
dimensions. Thus, diameters in range of 10-80 nm for wheat straw and 20-120 nm for soy 
hulls as raw materials have been reported [50]. On the other hand, NFC fibers isolated 
from sisal [82, 83], carrots [73], beet pulp [46, 56], and Luffa cylindrical [84] had 
diameters of 20-65 nm, 3-36 nm, 30-100 nm, and 40-70 nm, respectively.  
Hemicellulose and lignin residues also influence the fiber morphology. The raw 
material used for production of NFC normally contains lignin only in low quantities. 
However, studies of the effect of lignin content on the fiber dimensions have shown that 
the diameter of NFC fibers produced from lignin-containing pulp was larger regardless of 
the origin of the used pulp [85, 86]. On the other hand, the hemicellulose content 
correlates with smaller nanofiber dimensions, which suggests that hemicellulose limits the 
association between the cellulose nanofibers [66, 75, 87, 88].  
It is generally very difficult to create a clear picture on the effect of all factors on fiber 
dimensions, since each material source is specific and production methods differ from one 
study to another. 
NFC used in this thesis had a fibril width between 20 and 30 nm. A more detailed 
description of the material morphology and the methods used for its determination are 
given later in the materials section.   
2.2.2.2 Degree of polymerization and tensile strength 
Degree of polymerization (DP) for cellulose is reported to correlate strongly with the 
aspect ratios of the nanofibers; longer fibrils are associated with higher DP. Further 
mechanical treatment during NFC isolation affects the DP by decreasing its value with the 
increasing number of treatment cycles. Hence, mechanical isolation may result in about 
30–50% decrease in DP [39, 63]. The DP is also correlated to the NFC tensile strength, 
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where high DPs lead to high values of tensile strengths [63]. The exact values of tensile 
strength have not yet been precisely determined. However, the strength of NFC fibrils 
have been estimated to be at least 2 GPa based on the results for kraft pulp, which 
contained 70-80% of NFC fibrils distributed in a parallel direction [89]. NFC also 
possesses high toughness due to the high values of elastic modulus of the cellulose. Elastic 
modulus of a perfect crystal of native cellulose is estimated at 130 GPa to 250 GPa [47, 
90]. 
2.2.2.3 Rheological properties 
Aqueous suspensions of NFC form a highly entangled network, which behaves as a 
pseudoplastic gel [5, 42] showing a large decrease in viscosity with an increasing shear 
rate, a phenomenon which is referred to as shear thinning [42]. With regards to the 
influence of fibrillation method, the viscosity of NFC increases with the number of 
passages through the homogenization equipment. The rheological properties enable the 
use  of  the  NFC  as  thickener  or  stabilizer  in  suspensions  or  emulsions  [34,  38]  in  many  
applications such as foods, paints, cosmetics and pharmaceuticals. 
2.2.2.4 NFC in dry state  
In  this  thesis,  the  production  of  NFC  based  drug  delivery  systems  was  based  on  the  
property of NFC to aggregate upon water removal creating highly porous, water insoluble 
structures. Thus, the facts necessary to fully understand the mechanism behind this 
behavior must be understood.  
NFC is normally processed and stored as an aqueous suspension. This is done to avoid 
the agglomeration of the fibers during drying, caused by a phenomenon called 
hornification. The hornification defines irreversible changes in the natural structure of the 
fibers upon water removal [91]. It can be explained by an increased degree in cross-
linking in the material microstructure due to the formation of a large number of hydrogen 
bonds between the hydroxyl groups of neighboring fibers [88, 92]. Since this process is 
irreversible once dried, the material cannot be resuspended in water. This property has 
been used for the production of different dried forms of NFC. Hence, NFC has been 
converted into dry state to form aerogels, films and powders.  
When the water is removed from NFC gel by freeze-drying, highly porous (250-389 
m2/g), flexible and deformable aerogels are formed [5, 93]. These kinds of gels have been 
studied for numerous applications (e.g. drug delivery, catalysis, filtrations, grafts, 
cushioning and liquid storage) [7, 93-96].  
Diluted NFC suspensions have been converted to a dried powder form by spray drying 
[97, 98]. However, the powder form has still not found any applications. Thus, in this 
thesis, not only its usage as an excipient in pharmaceutical formulations, but its 
application in general, was tested for the first time. 
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The most studied dry forms of NFC are NFC films produced by filtration method [28, 
48, 99, 100], molding [101, 102] or spin coating [81]. When water is removed by any of 
these methods, films with tight fiber networks of high strength are formed. These films are 
sometimes referred to as nanofiber paper or nanopaper [81, 99-101]. Depending on the 
diameter of the NFC fibers the films show different degree of transparency which can be 
as high as 90% [103, 104]. Their application is based on their high strength and good 
barrier properties [99, 100]. However, the high hydrophilicity of NFC limits wide 
utilization of films made of pure NFC in some areas (e.g. in packaging). Thus, composite-
type films are often prepared by mixing NFC with other polymers [43, 44, 77]. 
2.2.3 Applications of NFC 
The most studied application of NFC is its utilization as a reinforcement material in 
nanocomposite materials. Numerous studies have reported superior mechanical properties 
of materials after the incorporation of NFC [39, 43, 47, 53, 77, 105]. However, in this 
thesis  work,  the  focus  was  on  the  utilization  of  NFC  as  a  pharmaceutical  excipient.  
Therefore, the following chapter will describe only selected biomedical applications of 
NFC. 
2.2.3.1 Biomedical applications of NFC 
In recent years, NFC of bacterial origin has been the most widely studied form of NFC 
in the biomedical applications. However, several studies have also explored possible 
applications of plant based NFC for these purposes. These applications are often based on 
the mechanical properties of NFC fibers. Mathew et al. [106] used NFC as material for the 
development of artificial ligaments and tendons. Partially dissolving NFC films in ionic 
liquids, they prepared cylindrical composites with mechanical properties similar or better 
than the natural ligaments and tendons. The composites also had excellent 
cytocompatibility required for biomedical applications. The same authors have also 
reported production of collagen based implantable scaffolds reinforced with the NFC 
[107]. They exploited the potential of NFC in providing mechanical reinforcement and 
dimensional stability to the newly created material without affecting the biocompatibility 
and non-toxicity of collagen. Eyholzer et al. [108] have created biocomposite hydrogels 
reinforced with carboxymethylated NFC for the replacement of nucleus pulposus in 
intervertebral disks. The hydrogels were prepared by UV polymerization of a mixture 
containing N-vinyl-2-pyrrolidone with Tween 20 trimethacrylate as a cross-linking agent 
and caroboxymethylated NFC powder. They created hydrogels that mimicked the swelling 
and mechanical behavior of human nucleus pulposus. Cherian et al. [109] have produced 
polyurethane matrices that were reinforced with NFC for implantable purposes. They 
tested  the  application  of  the  composites  in  design  of  prosthetic  heart  valves  as  well  as  
vascular grafts.  
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Besides its utilization based on excellent mechanical properties, NFC has found 
applications in biomedical sciences due to its high porosity and rheological properties.  
Bhattacharya et al. reported utilization of native NFC hydrogel as a scaffold for 3D cell 
cultures [110]. They found the rheological properties of NFC gel to be suitable for mixing 
with the cells and its fluid-like behavior at high-shear stress facilitated injecting. The 
spontaneously formed gel after the injection provided the required mechanical support for 
cell growth and differentiation [110]. Further, they showed that NFC material was not 
cytotoxic.  
Shimotoyodome et al. [111] studied the effect of intake of NFC (native and TEMPO- 
oxidized) on postprandial blood metabolic variables. NFC was orally administered with 
glucose and glyceryl trioleate to mice and blood levels of metabolic variables were 
followed over time. It was found out that the levels of blood glucose, insulin, glucose-
dependent insulinotropic polypeptide, and triglycerides were significantly decreased, 
especially 10 min after the administration of TEMPO-oxidized NFC.  
So far, the only applications of NFC in the field of drug delivery have been reported by 
Valo et al. [6, 7]. They showed that NFC can be successfully used for the stabilization of 
nanosuspensions [6]. This was achieved by nanoprecipitation of the drug in the presence 
of NFC and genetically engineered hydrophobin fusion protein (HFBI-DCBD), where the 
hydrophobin (HFBI) was coupled with two cellulose binding domains (CBD). The protein 
was utilized in order to assist binding of drug nanoparticles to NFC. The NFC 
nanostructure prevented the nanoparticles agglomeration significantly improving storage 
stability. Further, the nanoparticles embedded in NFC network preserved their 
morphology during the freeze-drying. In addition, the dissolution rate of itraconazole was 
significantly increased in vitro and in vivo due to the effect of nanosizing [6]. The concept 
of freeze-dried NFC networks as drug carriers was broadened and four different NFC 
aerogels with embedded drug nanoparticles were tested using NFC originated from 
different sources [7]. Drug release from the aerogels was immediate or sustained, 
depending on the structure and interactions formed by the nanoparticles and the cellulose 
matrix during freeze-drying. Thus, the NFC aerogel made from red pepper, and 
microcrystalline cellulose aerogel released the drug immediately, while bacterial cellulose, 
quince seed cellulose and TEMPO-oxidized birch cellulose aerogels showed sustained 
drug release. Both studies showed the potential of NFC to be used in many pharmaceutical 
nanoparticle applications and in controlled drug delivery.  
The publications listed above represent a collection of all reported biomedical 
applications of plant NFC so far. Evidently, NFC still has not found wide utilization in this 
area, especially not pharmaceutical field. Thus, this thesis aimed at exploring the 
applicability of NFC as an excipient in the formulation of pharmaceutical dosage forms.  
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2.3 Cellulose derivatives as pharmaceutical excipients 
Cellulose and its derivatives are widely used as pharmaceutical excipients. 
Microcrystalline cellulose (MCC) is used as tablet binder and diluent in wet granulation or 
in direct compression, and as a tablet disintegrant, anti-adherent or capsule diluent. 
Powdered cellulose is available in several grades and is used as binder and disintegrant. 
Ethylcellulose is hydrophobic, inert, stabile, cellulose derivative, frequently used in 
preparing sustained release dosage forms either as a tablet matrix-former material or film 
forming material [112-114]. Pure cellulose is not soluble in water due to its crystalline 
structure but, by incorporating substituents along the cellulose chains, the crystalline 
structure breaks down and cellulose derivatives such as hydroxypropyl (HPC), 
hydroxypropylmethyl (HPMC), and carboxymethyl cellulose (CMC) become water 
soluble. HPMC has found applications, depending on the molecular weight, in tablet film 
coating as well as rate controlling polymers in extended release hydrophilic matrices [115, 
116]. Carboxymethylcellulose is a typical acidic cellulose derivative and is used as 
emulsifier, gel-former, but also as binding agent or disintegrant in tableting [117, 118].  
Among all cellulose derivatives MCC could be recognized as the most commonly used 
as excipient in pharmaceutical formulations. It has been widely used as filler for tablet 
production and according to the survey conducted within the pharmaceutical industry it is 
considered the most useful filler for direct compression [119]. In this thesis, application of 
NFC as a filler for tablet production was studied and compared to MCC due to their 
physico-chemical similarities. Thus, the following chapter more closely describes the 
application of MCC in tablet manufacturing.  
2.3.1 Microcrystalline cellulose as filler for tablet production 
Microcrystalline cellulose is manufactured by controlled hydrolysis of dilute mineral 
acid solution of cellulose, obtained as a pulp from fibrous plant materials. Following 
hydrolysis, the hydrocellulose is purified by filtration and the aqueous slurry is spray-dried 
to form dry, porous particles of a broad size distribution. Considering this, MCC and NFC 
are chemically identical and they also utilize the same method of conversion of an aqueous 
slurry to the powder form (spray drying). Thus, it could be expected that spray dried NFC 
could be utilized for the same purpose as MCC when formulating tablets as dosage form. 
MCC has been employed as a tableting excipient in pharmaceutical manufacturing for 
more than 30 years [119].  
A material should fulfill certain criteria in terms of powder characteristics in order to 
be successfully used as tablet filler. It should: i. possess good flowability to ensure 
uniformity of tablet weight, ii. be readily mixed with other ingredients without showing 
signs of segregation to ensure homogeneous mixtures and obtain tablets with an 
acceptable uniformity, iii. have suitable compression pressure – tablet strength profile to 
produce the tablets with high physical strength when applying low compression forces, iv. 
possess high dilution potential so that a high amount of another ingredient can be mixed 
with it while still obtaining tablets of acceptable quality, v. be physically and chemically 
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stable and inert with regard to moisture, air, and heat as well as active ingredients or other 
excipients, and vi. possess a known mechanism of consolidation during compression so 
that it complements the properties of an active ingredient. This thesis evaluated spray 
dried NFC in terms of some of the mentioned properties in order to estimate its potential 
as  tablet  filler  and  also  in  order  to  compare  those  properties  of  NFC  to  MCC.  The  
popularity of MCC as tablet filler can be ascribed to its fulfillment of the majority of the 
above mentioned criteria. MCC is well known to deform in a predominantly plastic 
manner during the compaction. In general, early stages of compaction are characterized by 
particle rearrangement, break down of the particles agglomerates, and deformation or 
breaking of the granules for granulated powders. The density of the die content is 
increased and when the particles are close enough interparticlulate bonds are created. 
Further increase in the pressure causes the change in particle shape and some type of 
deformations including plastic deformation or breakage of particles, consolidation of 
particle segments and bond formation between them. When the load is removed in 
decompression  step,  some  particles  are  able  to  regain  their  original  shape  (elastic  
deformation), while other ones have experienced permanent deformation (plastic 
deformation) (Figure 6 A) [120]. Thus, the plastic deformation has been defined as a 
permanent change in the shape of a specimen due to the applied stress. This kind of 
deformation aids interparticulate bonding, because it increases the contact area between 
particles. In this way, strong tablets are prepared. The force required for initiation of 
plastic deformation is denoted as yield stress. On the other hand brittle particles undergo 
fragmentation when fracture occurs by the rapid crack propagation throughout the 
specimen crushing original particle in smaller units (Figure 6 B) [120, 121].  
 
Figure 6 Plasticity, elasticity and fragmentation in powder system during compression (A) and 
stress strain curve showing the behavior of a material under the stress (B). 
A B 
 
  Literature review 
 
 
 
15 
 
A single particle may undergo several of these deformation stages during the 
compression process. Some materials mainly consolidate by plastic deformation 
(microcrystalline cellulose, mannitol, starch, sodium chloride) and some mainly by 
fragmentation (lactose, calcium hydrogen phosphate, sucrose), but all materials possess 
both elastic and plastic behavior depending on the applied force [121]. In the case of 
MCC, hydrogen bonding plays an important role in compact hardness [122, 123]. 
Hydrogen bonding is important because significant plastic deformation during 
compression brings an extremely large surface area into close contact and facilitates 
hydrogen bond formation between the plastically deformed, adjacent cellulose particles 
[124]. Considering that NFC also possesses hydroxylic groups capable of building 
hydrogen bonds it could be expected that similar phenomena takes place when NFC is 
used as tablet filler. Apart from the chemical similarity of MCC and NFC, certain degree 
of  difference  in  terms  of  particles  size  and  morphology,  moisture  content  as  well  as  
crystallinity could be expected. It has been shown that these factors can influence the 
properties of the produced tablets [122, 123, 125-128]. Hence, certain differences in 
compression behavior of MCC and NFC were expected. 
One of the aims of the thesis was to show if NFC could be used as tablet filler, on the 
other hand the main goal was to further explore its potential as pharmaceutical excipient in 
creation of controlled drug delivery systems. Thus, the following chapter focuses on 
discussion  of  the  most  important  types  of  controlled  drug  delivery  systems  and  
mechanisms of drug release from those systems.  
2.4 Controlled drug delivery 
Periodic administration of a drug by conventional means, such as taking a tablet every 
four to eight hours or injecting a drug intravenously or subcutaneously, results in 
constantly changing systemic drug concentrations in the blood stream. This often produces 
a sharp initial increase in drug concentration to the level above the therapeutic range and it 
is followed by fast decrease in drug concentration below the therapeutic range [129] 
(Figure 7). Drug delivery systems (DDS) with controlled release attempt to maintain drug 
concentrations in the therapeutic level over a certain period of time. Thus, they offer 
several advantages over immediate release systems, including precise control of dose, 
decreased number of dosages, reduction in harmful side effects, and improvement in 
patient compliance and convenience. 
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Figure 7 Simplified blood level profiles illustrating the difference between repeated treatment 
with a conventional immediate delivery formulation and a single, controlled release, long-acting 
formulation [129] 
A number of advancements have been made in the past 30 years in the development of 
new techniques for controlled drug delivery. These techniques are capable of regulating 
the rate of drug delivery, sustaining the duration of therapeutic action, and/or targeting the 
delivery of drug to a specific tissue [130, 131]. Based on the technical complexity, the 
DDSs with a controlled drug release that have been marketed so far, or that are under 
active development, can be classified as follows [132]: 
? Rate-preprogrammed drug delivery systems -  release  of  drug  molecules  from  the  
delivery systems has been preprogrammed at a specific rate profile. This is 
accomplished by system design where the drug release is controlled by several 
physical  and  chemical  phenomena  and  their  combinations,  e.g.,  wetting  of  the  
system’s surface with water, water diffusion in the system, drug dissolution, drug 
diffusion, polymer swelling, polymer dissolution, and/or polymer degradation, 
physical drug-excipient interactions, etc. [133, 134]. If several processes take place 
simultaneously, the one which is much slower than all the others is considered as 
dominant and needs to be taken into account for the quantitative description of the 
overall drug release rate from the device [133]. Thus, depending on the 
predominant/limiting process, the rate-preprogrammed DDSs can roughly be classified 
as: 
? Diffusion controlled DDS (reservoir and monolithic systems),  
? Water penetration controlled DDS (osmotic and swelling systems) 
? Chemicaly controlled DDS (biodegradable systems and ion exchange 
resins).  
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? Activation-modulated drug delivery systems -  release  of  a  drug  takes  place  when  
triggered by specific internal or external stimuli, such as changes in pH [135-137] or 
temperature [138, 139], exposure to ultrasound [140], enzymes [141, 142]  or light 
[143], or changes in electric [144, 145] or magnetic fields [146]. 
? Feedback-regulated drug delivery systems - ability to monitor the chemical 
environment and rapidly detect and appropriately respond to a biological event by 
changing the rate of release of a therapeutic agent [147]. 
? Site-targeting drug delivery systems – ideally have ability to deliver a drug 
exclusively  to  the  targeted  cells  or  cellular  components  thus  offering  the  best  
controlled mechanism [148]. 
2.4.1 Diffusion controlled drug release 
Diffusion is the most important mechanism used to control the drug release from 
DDSs [149]. Depending on the inner structure, the diffusion controlled DDSs are usually 
classified as reservoir type DDSs, which comprise “core-shell structure”, in which the 
drug is physically separated from the rate-controlling membrane, and monolithic DDSs, 
where the drug is homogeneously distributed within the matrix (Figure 8). Both the 
reservoir and monolithic DDSs can be further classified depending on the initial drug 
loading compared to the drug’s solubility.  
2.4.1.1 Reservoir systems 
When talking about reservoir DDSs, it is possible to distinguish between “non-constant 
activity source” and “constant activity source” systems (Figure 8) [133, 150]. In non-
constant activity source systems, the concentration of a drug within the system is below its 
solubility (e.g. coated pellets or tablets with a low drug loading). Thus, the drug 
concentration in the reservoir is decreasing over time. Drug release from these types of 
systems follows first order kinetics regardless of the geometry of the device given that the 
membrane does not dissolve or swell, the diffusion coefficient remains constant and sink 
conditions are provided [134]. In constant activity source systems, the drug concentration 
within the device exceeds the drug solubility. This results in the drug dissolution from the 
“depots” of amorphous or crystalline solid substance keeping the drug concentration 
constant over the time. As long as the excess of drug is present, zero order release kinetics 
is achieved regardless the system geometry, given the same conditions as mentioned 
above. Once the excess drug is dissolved and the concentration within the reservoir falls 
below drug solubility, the system becomes a non-constant activity source [134].  
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Figure 8 Classification system for primarily diffusion controlled drug delivery systems. Stars 
represent individual drug molecules, black circles drug crystals and/or amorphous aggregates. 
Only spherical dosage forms are illustrated, but the classification system is applicable to any type 
of geometry [134]. 
2.4.1.2 Monolithic systems 
Similarly to drug delivery reservoirs, the monolithic systems can be classified based on 
the initial drug loading/drug solubility ratio. Here we can make distinction between 
monolithic solutions and monolithic dispersions (Figure 8) [133].  
 
Monolithic solutions 
The system is considered a monolithic solution if the initial drug concentration is 
below drug solubility, thus, the drug is moleculary dispersed in the matrix former or if the 
drug is rapidly completely dissolved upon water penetration into the system [150]. Drug 
release kinetics from monolithic solutions is significantly dependent on the system 
geometry. In this thesis work we produced systems which could be described as 
monolithic dispersions. Hence, the equations for the calculation of drug release from 
monolithic solutions are not presented here but later in the experimental part of the thesis. 
Monolithic dispersions 
The system can be classified a monolithic dispersion if the drug is homogeneously 
distributed within the matrix former in the form of crystalline and/or amorphous particles 
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meaning that the initial concentration is above drug solubility (in the wetted state) [133]. 
When this type of a system is exposed to an aqueous medium, the drug in the outermost 
layer starts to dissolve and becomes available for diffusion. Once the drug from that layer 
has completely dissolved, the same process starts in the adjacent layer. Thus, the dissolved 
and non-dissolved drug fractions co-exist within the matrix. The drug release kinetics 
from these systems is also highly dependent on the geometry (Figure 9). Often the exact 
mathematical description of drug release can be rather complex. However, in case of thin 
films with the release from both faces and negligible edge effects (slabs),  a quite simple 
equation has been derived 50 years ago by Takeru Higuchi [151, 152]: 
(1) tCCDCAM sinist )2( ??  
where Mt is the cumulative absolute amount of drug released at time t; A is total surface 
area of the film exposed to the release medium; D is the diffusion coefficient of the drug 
within the system; Cs is the solubility of the drug in the wetted matrix (not in the release 
medium), and Cini is the initial total concentration of the drug in the system. When 
applying the Higuchi equation, one should keep in mind that the equation is valid only in a 
case when: i. the drug transport through the matrix is the rate limiting step (while drug 
transport  in  release  medium  and  water  penetration  into  the  system  are  rapid),  ii.  the  
dissolution of the drug particles within the system is rapid compared to the diffusion of the 
dissolved fraction, iii. perfect sink conditions are provided, iv. the initial drug 
concentration in the system is much higher than the drug solubility in the wetted system, 
v. the drug is homogeneously distributed and finely dispersed (the size of the particles is 
much smaller than thickness of the film), vi. the diffusion coefficient of the drug within 
the system is constant, and vii. the system does not swell or dissolve during the release.  
 
 
Figure 9 Overview on the mathematical equations, which can be used to quantify drug release 
from monolithic dispersions (initial drug concentration > drug solubility). The variables are 
explained in the text [150]. 
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The best solutions to quantify drug release from monolithic dispersions with spherical 
and cylindrical shapes so far were offered by Baker and Lonsdale [153]: 
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where Mt and M? are  the  cumulative  amounts  of  drug  released  at  time  t and at infinite 
time, respectively; D is  the diffusion coefficient of the drug within the system; Cs is the 
drug solubility in the wetted matrix (not in the release medium); Cini is the initial drug 
concentration in the system, and R is the radius of the sphere. 
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where R is the radius of the cylinder 
This chapter gave an overview on main types of controlled drug delivery systems and 
mechanism of drug release from those systems. Considering that in the most cases 
different types of polymers are used for formulation of those systems the following 
chapter will focus on polymers and their application in formulation of DDSs with long-
lasting drug delivery. 
2.4.2 Materials for long-lasting parenteral drug delivery systems 
 
The main aim of this thesis was to produce systems based on NFC as matrix former 
which would sustain release of a drug for long time period, preferably up to three months 
or longer. The idea originated from the existence of a continuous demand for new 
sustained release drug delivery techniques, which could be utilized for production of 
systems such as transdermal patches, intraocular devices or gynaecological devices such 
as intravaginal rings, intrauterine devices or implants for subcutaneous delivery. The 
duration of drug release from these systems can range from 24 h to 1 week for transdermal 
patches, 1 month to 28 months for intravaginal rings or 6 months to 1 year for implants.  
The number of currently available polymers which could provide the needed duration 
of therapy is limited. It should also be taken into account that polymers whose mechanism 
of controlling drug release is based on swelling are not suitable for these purposes. Further 
biodegradable polymers (e.g. poly(lactide-co-glycolide)) are known to have disadvantages 
such as inter-patient variance, inability of system removal in the case of need for therapy 
discontinuation. Besides this, the design of some of the mentioned systems (intravaginal 
rings or intrauterine devices) would be rather complicated when biodegradable polymers 
are used due to the necessity of the systems to keep their shape and mechanical properties 
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during the whole duration of therapy. Thus, only a small number of non-biodegradable, 
non-swelling polymers are available for the design of such long-lasting drug delivery 
systems. Nowadays, the most popular materials for this purpose are poly(ethylene-co-
vinylacetate) (EVA) and silicone elastomers such as poly(dimethylsiloxane) (PDMS). 
Good example of the products present on the market which utilize EVA is the intravaginal 
contraceptive ring Nuvaring® (developed by Organon), which provides sustained release 
of etonogestrel and ethinylestradiol for a period of three weeks. The same material has 
been used for the production of the contraceptive implantable rod Implanon® (developed 
by Organon), which delivers progestin etonogestrel for a period of 3 years. PDMS has also 
been successfully employed in the products widely available on the market. The 
subcutenous implant Jadelle® (developed by the Population Council and manufactured by 
Leiras Inc., nowadays Bayer Inc.) is used for the sustained release of levonorgestrel for a 
time period of 5 years.  Another good example of successful application of PDMS is the 
intrauterine device Mirena® (developed by the Population Council in the late 1980s and 
later with Schering Inc., nowadays Bayer Inc.) which comprises of a T-shaped backbone 
of PDMS with a drug delivery cylinder wrapped around its stem. The cylinder is a 
PDMS/levonorgestrel mixture that allows a steady release of levonorgestrel through 
regulating surface membrane for period of 5 years.  
From the examples above it is clear that intravaginal rings and implants have, to date, 
been primarily developed for the systemic delivery of contraceptive steroids and the 
localized and systemic delivery of steroids for hormone replacement therapy. However, it 
is likely that they will, in the future, be exploited for a much wider range of applications 
within women’s health care in general. This brings to discussion the limitations of 
materials currently used for the production of the devices. The delivery of the drugs from 
the mentioned materials is based on the diffusivity of steroid compounds due to their high 
solubility in the hydrophobic material and the relatively low molecular weight/volume. 
Therefore, the currently used materials are not suitable for the delivery of hydrophilic 
and/or high molecular weight compounds. Furthermore, all the currently used materials 
are thermoplastic and the devices are often produced by extrusion or injection molding. 
Both the processes require relatively high temperatures which makes them unsuitable for 
incorporation of thermosensitive drugs. Furthermore, silicone elastomers require a curing 
step to achieve the desirable mechanical properties and the curing process is performed at 
an elevated temperature. All the mentioned limitations lead to conclusion that new, more 
versatile materials for long lasting drug delivery are needed. Thus, the aim of this thesis 
was to test application of NFC for these purposes.  
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3 Aims of the study 
The aim of this thesis was to evaluate the potential of NFC to be used as an excipient in 
the production of pharmaceutical dosage forms, especially 1. as an excipient for 
immediate release tablets and compressions, and 2. for providing sustained drug release 
profiles from microparticle and film-type controlled release systems. 
 
The specific objectives of this study were: 
 
1. To study the applicability of NFC as a novel excipient for the production of 
tablets with immediate drug release properties. The specific goal was to 
investigate the use of spray dired NFC as a filler in tablet production in direct 
compression and  wet granulated formulations (I) 
 
2. To investigate the applicability of NFC in production of spray dried drug 
loaded microparticles which will act as long-lasting (several months) drug 
release systems (II) 
 
3. To investigate preparation, drug-loading capability and sustained release 
properties of drug/NFC film-like matrix systems aiming at the drug loadings in 
the range of 20% – 40% and long-lasting drug release (up to three months) 
(III)   
 
4. To study physical and chemical interactions between the NFC fibers and model 
drugs, peptides and proteins with different molecular properties (structure, 
molecular weight/size, charge) (IV)  
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4 Experimental 
Complete details of the suppliers of the materials, production and analytical methods and 
equipment used in this work can be found in the original publications (I-IV). 
4.1 Materials  
4.1.1 Nanofibrillar cellulose (I-IV) 
The nanofibrillar cellulose was produced and kindly donated by UPM-Kymmene 
Corporation, Finland. Bleached birch pulp was used as the NFC source. Purified pulp 
fibers were diluted with sterilized, ultra high quality water before the fibrillation. Fibers 
isolation was conducted via controlled homogenization process using an industrial 
fluidizer. The applied process resulted in the production of nanofibrillar cellulose hydrogel 
with  the  fiber  content  typically  1.7  wt%.  Analysis  of  the  NFC  product  with  an  electron  
microscope revealed that the most common fibril width is between 20 and 30 nm (Figure 
10). The exact length scale cannot be estimated due to the entangled and bundled nature of 
the material. Detailed description of the fibers size distribution has been presented 
elsewhere [154]. The product also contains some soluble hemicelluloses, i.e. 23 wt% of 
xylan, due to the birch based raw material. 
 
Figure 10 SEM image of NFC hydrogel (A), the scale bar 100 nm, fibril width distribution 
measured manually from FE-SEM image (B) (This picture was provided by Dr. Antti Laukkanen 
from the UPM company) 
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4.1.2 Model compounds (I-IV) 
The list of the model drug compounds used in the studies and their most important 
physicochemical properties are given in Table 2. 
Table 2. List of the model drug compounds, their aqueous solubilities, pKa values, and 
molecular weights. 
API Solubility in aqueous media pKa/pI 
Molecular 
weight (g/mol) Reference 
Paracetamol 17.39 mg/ml 9.5 151.2 [155, 156] 
Ibuprofen < 1 mg/ml 6 mg/ml pH=7.4 5.2 206.3 [157, 158] 
Nadolol 6.77 mg/ml 9.4 309.4 [159] 
Atenolol 26 mg/ml 9.6 266.3 [160, 161]  
Metoprolol tartrate freely 9.5 684.8 [162, 163] 
Verapamil 
hydrochloride 70 mg/ml 8.9 491.1 [164-167] 
Indomethacin 
6 µg/ml MQ 
13 µg/ml pH=5 
302 µg/ml pH=7.4 
4.4 357.8 [168-170]  
Itraconazole <1 µg/ml 3.7 705.6 [171] 
Beclomethason 
dipropionate <1 µg/ml 15.6 521.1  
Nafarelin acetate >10 mg/ml 5.9/9.9/12.5 1322.5 [172] 
Lysozyme >10 mg/ml 11.1 14300.0 [173, 174] 
4.2 Production techniques 
4.2.1 Tableting (I) 
Spray dried NFC powder was compared to two commercially available grades of 
microcrystalline cellulose (MCC); Avicel PH 101 and Avicel PH 102. MCC was chosen 
for the comparisons due to its similarity to NFC in chemical structure, and Avicel PH 101 
and Avicel PH 102 are the two most commonly used grades of MCC. Determination of 
the  powders’  main  physical  characteristics  was  done  as  well  as  examination  of  their  
compression behavior. Tablets were compressed from both dry powder mixtures and 
granules. For direct compression studies, dry powder mixtures were prepared by mixing 
the ingredients using a Turbula blender, (System Schatz, Willy A. Bachofen AG, 
Switzerland) for 2 minutes. For compression after granulation, granules were produced 
manually (using mortar and pestle) by a wet granulation process. Tablet compression was 
performed using an instrumented single punch tableting machine (Korsch EK-0, Erweka 
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Apparatebau, Germany) equipped with flat-faced 9 mm punches. The adjustments of the 
tablet machine were kept constant in all compressions in order to ensure the same speed 
(37 rpm) of the upper punch and the even thickness of the tablets in all cases. The powder 
die was filled manually with gradually increasing amounts of powder/granules to provide 
desirable increase in compression force. 
4.2.2 Spray drying (II) 
Suspensions for the spray drying process were prepared by dissolving a drug in a suitable 
solvent (MQ water or 50 mM aqueous NH4OH). The solutions were then mixed with NFC 
suspension so that the total concentration of the both, dissolved and suspended material, 
was 0.5%. The prepared suspensions were sonicated for 15 min using a high intensity 
ultrasound processor (Sonics, Newtown, USA) equipped with a 13 mm probe, and then 
mixed with a mechanical stirrer for 15 min at a speed of 1800 rpm. The spray drying was 
performed using a Mini spray dryer Büchi B-191 (Büchi, Switzerland). The operating 
parameters were set as following: inlet temperature 220 °C, outlet temperature in a range 
from 120 – 127 °C, spray flow 700 l/h, air pressure 7 bar, aspirator setting 95% and pump 
setting 18% (corresponds to approx. 7 ml/min). The spray dried microparticles were 
collected from the dryers’ collection vessel and stored in closed vials at room temperature. 
The spray dryer was equipped with a two-fluid nozzle and operated in a co-current mode 
(the feeding suspension and the drying air flow in the same direction). 
4.2.3 Drug-loaded NFC films production (III) 
Drug loaded NFC matrices were produced using water insoluble model drug compounds. 
The chosen drugs were mixed with a highly viscous NFC suspension and the mixtures 
were sonicated for 2 min using a high intensity ultrasound processor (Sonics, USA) 
equipped with a 2 mm stepped microprobe adjusted at power of 750 W and 20 kHz 
frequency. The prepared mixture was diluted with water at 1:1 ratio to make pipetting of 
the highly viscous mixture easier, and to have an even distribution during the filtration 
process. The suspension was then filtered through a PVDF membrane filter with 0.2 µm 
pore size. During the filtration process, the water insoluble drug particles remained on the 
filter and were entrapped within a network of fine cellulose fibers. After the filtration, the 
wet matrices were dried in an oven for 4 h at a 65 °C.  
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4.3 Characterization techniques 
4.3.1 Drug interactions with NFC fibers (IV) 
Interactions between the model drug compounds and NFC fibers, as well as xylan, 
were studied by following thermodynamic changes during the binding events. This was 
done using an isothermal titration calorimetry technique (ITC). Calorimetric experiments 
were performed using a Microcal Isothermal Titration Calorimeter (MicroCal, MA). A 
sample cell (with a volume of 1.8 ml) was filled with either aqueous NFC suspension or 
aqueous xylan solution. The xylan concentrations were chosen to match the concentration 
of xylan present in NFC suspension used for titrations. The experiments were performed 
at 25 °C by injecting 10 µl of aqueous drug solutions to the sample cell which was stirred 
at 300 rpm. The observed released heat included the heat of the drug binding to the NFC 
fibers and the heat of dilution of the drugs to the water. To determine the heat of dilution, 
blank titrations were made by injecting the drug solutions into the sample cell filled with 
MQ water. The differential enthalpy curves of heat of dilution were then subtracted from 
the curves of the binding of drugs to the NFC fibers. Data analysis was performed using 
Microcal ORIGIN software. Titrations were also performed using a genetically engineered 
fusion  protein  (HFBI-DCBD)  as  a  positive  control,  since  its  affinity  and  capacity  of  
binding for NFC has already been reported [175]. 
4.3.2 Characterization of produced drug release systems (I-III) 
4.3.2.1 Tablet characterization (I) 
Produced tablets were characterized in terms of their thickness, mass and mechanical 
properties. The thickness of the tablets was measured 24h after the compression and the 
obtained values were used to calculate the tablet porosity. The Heckel plots were then 
constructed  by  plotting  the  natural  logarithm  of  the  inverse  of  the  tablet  porosities  as  a  
function  of  the  compression  pressures.  Regression  analysis  was  performed  on  the  linear  
portion of the curve. The slope values obtained were converted to yield pressures (Py) 
using the relationship: Py =1/slope. 
4.3.2.2 Electron microscopy (I-IV) 
Morphology of the starting material for compression (I), spray dried drug-loaded 
microparticles (II), drug loaded NFC films (III) and plain NFC films (IV) were studied by 
scanning electron microsope (SEM) Zeiss DSM 962 (Carl Zeiss, Germany) and FEI 
Quanta™ FEG (FEI, Oregon, USA). For the powder imaging (I-II), the dried powder 
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samples were fixed onto a two-sided carbon tape. For the imaging of drug-loaded NFC 
film (III) the samples were fractured manually or cut with a scalpel to study the 
morphology of films cross-section. For the imaging of plain NFC films (IV), the samples 
were cryo-fractured using liquid nitrogen for studying the inner structure. All the samples 
were sputtered with platinum for 25 seconds with an Agar sputter device (Agar Scientific 
Ltd., UK). 
4.3.2.3 Solid state analyses (II-III) 
Thermal analyses of the spray dried drug-loaded NFC microparticles (II) and drug-
loaded NFC films (III) were performed by differential scanning calorimeter (DSC) 
Mettler Toledo DSC 823e (Mettler Toledo, Switzerland). The samples were placed in 
sealed aluminum pans with pierced lids and held at 25°C for 5 min before heating. The 
experiments were conducted at a heating rate of 10 °C/min in the temperature range 
between 25°C and 200°C or 250°C depending on the sample. The data was analyzed with 
STARe software (Mettler Toledo, Switzerland). 
Physical state of the drugs within the drug-loaded NFC films (III) was estimated by X-
ray powder diffraction (XRPD) using a theta-theta X-ray diffractometer (D8 Advance, 
Bruker AXS GmbH, Germany). The measurements were performed in symmetrical 
reflection mode with Cu K? radiation (?=1.54Å) using a Göbel mirror. The angular range 
was 5° to 40°. The measurements were made with the steps of 0.02°, and the measuring 
time was 2 s/step. 
4.3.2.4 Dissolution studies (I-III) 
Dissolution tests for the tablets (I) were performed using a paddle type dissolution 
apparatus (Erweka DT-D6, Germany) with a rotation speed of 50 rpm and 900 ml of 
purified  water  at  37±0.5°C  as  a  medium.  After  each  sample  (500  µl),  the  volume  was  
replaced by the same amount of medium. The samples were filtered through 0.45 µm 
filters and analyzed using UV spectrophotometer (Pharmacia LKB Ultrospec III, Sweden). 
Dissolution tests for the drug-loaded spray dried particles were performed after the 
surface unbound fraction of the drug had been removed. The surface fraction was washed 
and quantified by placing 40 mg of the microparticles on a hydrophilic polypropylene 
membrane  with  a  pore  size  of  0.2  µm and washing  with  400  ml  of  the  medium using  a  
vacuum filtration system. After this step the samples were transferred to 50 ml glass 
bottles with 10 ml of medium. The bottles were placed into a shaking water bath (Julabo 
SW 23, Germany) equipped with a tray for the Erlenmeyer flasks. Shaking frequency was 
set at 100 min-1. At various time points the total volume of dissolution medium was 
replaced by fresh medium. This was done by filtering the particles from the dissolution 
medium and resuspending them in the same volume of fresh medium. The amount of the 
released drug was quantified by a suitable HPLC method (Agilent 1100 series, CA, USA).  
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Dissolution tests for the drug-loaded NFC films were also performed after the fraction 
of the drug located on the film surface was removed. For the determination of surface 
fraction, pieces of the films (4.5 mg) were cut and placed into vessels of the standard 
dissolution equipment (Sotax, Switzerland, paddle method, Ph. Eur. 7th) that contained 
400 ml of a medium. The samples were left in the medium overnight with a paddle 
rotation speed of 60 rpm and then transferred to 50 ml glass bottles with 25 ml of medium 
and placed into a shaking water bath (Julabo SW 23, Germany) equipped with a tray for 
the Erlenmeyer flasks. Shaking frequency was set to 100 min-1. Samples of the medium 
were taken at various time points and analyzed by a suitable HPLC method. The total 
amount of medium (25 ml) was exchanged with a fresh medium after every sampling. 
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5 Results and discussion 
5.1 NFC as a tableting excipient (I) 
5.1.1 Physical characterization of the spray dried NFC 
Spray dried NFC particles were characterized in terms of their main physical 
properties relevant for the potential application as a novel filler in tablet production. Its 
main characteristics were then compared to those of two commercially available grades of 
microcrystalline cellulose (MCC); Avicel PH 101 and Avicel PH 102. The commercially 
available MCCs show broad particle size distributions with main diameters of 50 µm for 
Avicel PH 101 and 100 µm for Avicel PH 102. Spray dried NFC had more uniform, 
smaller particles which were 5 - 10 µm in diameter (Figure 11). A difference in surface 
morphology was also apparent with irregularly shaped MCC particles versus more 
spherical, porous NFC particles formed by the web of fibrils. 
Figure 11 SEM images of Avicel PH 101 with ×1,000 magnification; scale bar 20 µm (a), 
spray-dried NFC with magnification ×2,000; scale bar 20 µm (b), and ×10,000; scale bar 2 µm 
(c) 
The particle size and spherical shape play important roles in powder flow, thus 
resulting in better flowability of the NFC than Avicel PH 101 and also improved flow 
properties of Avicel PH 102 with the addition of NFC (Figure 12). 
 
 
Figure 12 Flow properties of Avicel PH102 
(closed circle) and mixtures containing Avicel 
PH102 and 10% (open square), 20% (closed 
triangle), and 30% (open circle) of NFC 
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5.1.2 Direct compression studies 
For the direct compression studies, tablets were prepared of pure NFC powder as well as 
of the mixtures of NFC and MCC. The Heckel plots were constructed and values of yield 
pressure calculated (Table 3) in order to gain more knowledge on the material deformation 
properties during the compression process. Ductile materials which undergo plastic 
deformation during the compression process are characterized by a dominant linear region 
in the Heckel plots. The slope of the Heckel plots and, consequently, the values of yield 
pressure are a measure of the degree of material plasticity, with steeper curves and lower 
values of yield pressure indicating a more pronounced ductile component.  
Table 3. Regression analysis of mechanical properties of Avicel PH 102, spray-dried NFC, 
and their mixtures (A2 and C  denote Avicel PH 102 and NFC, respectively, and A2C1, 
A2C2,and A2C3 mixtures containing Avicel PH 102 and 10%, 20% and 30% of NFC, 
respectively).    
Formulation Compression pressure 
range (MPa) 
R2 Slope Yield pressure 
Py (MPa) 
A2 25-76 0.9935 0.0133 75 
C 30-97 0.9984 0.0090 111 
A2C1 25-72 0.9905 0.0128 78 
A2C2 25-72 0.9920 0.0131 76 
A2C3 25-72 0.9973 0.0131 76 
 
It has been shown that MCC experiences a plastic deformation during the compression 
process [122-124, 176]. Values of the slope of the Heckel plots lead to a conclusion that 
NFC has less pronounced ductile characteristics. These findings were further supported by 
the values of yield pressure. The values of yield pressure lower than 80 MPa indicates a 
plastic behavior of the material, while higher values imply brittle characteristics [177]. 
Thus, compared to MCC, NFC has more pronounced brittle characteristics and its 
deformation is characterized by particle fragmentation.  
 
Figure 13 Effect of compression pressure on 
the tensile strength of tablets made of Avicel 
PH102 (closed diamond), spray dried NFC (open 
circle), and mixtures containing Avicel PH102 
and 10% (open diamond), 20% (closed triangle), 
and 30% (asterisk) of spray-dried NFC by direct 
compression method. 
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The mechanical properties of tablets were evaluated and the relationship between 
tablet strength and compression pressure analyzed. Linear relation was found for all the 
tested batches under the studied conditions. Spray dried NFC formed noticeably weaker 
tablets than Avicel PH 102 under the same applied pressure (Figure 13). The same 
behavior was noted when a model active compound (paracetamol) was added to the tablet 
formulation.  
5.1.3 Tableting after the granulation 
Tablets were compressed from two batches of granules containing 40% and 60% of 
paracetamol as a model active compound. The mechanical properties of the tablets were 
evaluated  in  the  same  way  as  after  the  direct  compressions.  Plots  of  compression  force  
against tensile strength were constructed as well and showed the same trend as in the cases 
of direct compression as a tablet production method. The tablets made of the granules 
containing NFC were weaker than those containing Avicel PH 101 and Avicel PH 102, 
when the same compression pressure was applied (Figure 14). However, this difference in 
tablet strength was less pronounced than in the case where the direct compression method 
was used. This is explained by the fact that the plasticity of MCC is significantly reduced 
after the wet granulation step is applied [122]. 
 
  
 
Figure 14 Effect of compression pressure on the tensile strength of tablets made from granules 
containing 40% (A) and 60 % (B) of paracetamol and Avicel PH101 (closed squares), Avicel 
PH102 (open triangles), spray dried NFC (open diamonds), and mixture of Avicel PH101 and 
spray dried NFC (closed circles). 
The study showed that spray dried NFC can be successfully employed as an excipient for 
tablet production. However, this thesis further aimed at exploring the applicability of NFC 
as pharmaceutical excipient, while specifically focusing on its application as material for 
sustained drug delivery.   
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5.2 Spray dried drug loaded NFC microparticles for sustained 
drug release (II) 
5.2.1 Microparticles production by spray drying 
Spray drying has been utilized since the early 1940s [178, 179] as a tool for processing 
pharmaceuticals. It offers a possibility of adjusting the product properties (such as particle 
size, shape) and production in a continuous mode. We produced matrix structured 
microparticles with NFC as a carrier material and drug incorporated within a porous fiber 
network (II). The microparticles were produced by spray drying the suspension prepared 
by mixing drug solution in a suitable aqueous solvent and dispersion of NFC fibers. Since 
NFC creates highly viscous gel-like dispersions in concentrations over 1.5% [5, 42], the 
concentration of feeding suspension for the spray drying had to be kept low (total solid 
content  of  0.5%).  This  factor  combined  with  a  high  affinity  of  NFC  to  water  and  short  
retention time of drying material in the drying chamber required a high temperature for 
successful drying. Thus, drugs with suitable thermal stability and melting point were 
chosen as model active pharmaceutical ingredients (APIs). During the spraying process, a 
problem of adherence of non-completely dried particles was encountered, which resulted 
in low yields of the production process (yields were in a range of 19.2% - 35.2%). Further, 
due to the different drying kinetics of the drugs and NFC, a certain portion of drug was 
dried separately causing a decrease in the targeted drug loading (final loading in the range 
of 4.5% - 15.1%).  
5.2.2 Microparticle characterization 
As a consequence of agglomeration of the NFC fibers in the drying process, the produced 
microparticels had diameters of around 5 µm, roughly spherical shapes and fibrous surface 
structures (Figure 15). The particle morphology was similar as in the study (I), which 
meant that the incorporation of an API does not affect the particle formation during the 
spray drying process.  
Spray drying, as many other processing steps, is known to cause changes in the solid 
state of the processed drugs [180]. For that reason, a physical state of the drugs within the 
spray dried microparticles was evaluated by thermal analysis. It was found that the 
particles production process mainly caused a transformation of the crystalline drug form to 
an amorphous state, which is in accordance with previous findings that spray drying 
results in the production of amorphous materials [180-182]. However, small portion of the 
drug crystallized after the spraying. In indomethacin loaded microparticels, the existence 
of two polymorphic forms, ? and ?, was detected.  
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Figure 15 SEM images of the spray dried NFC microparticles: (A) particles containing 20% of 
metoprolol imaged with lower magnification (scale bar 5µm) and (B) higher magnification (scale 
bar 3 µm), and (C) particles containing 20% of verapamil imaged with lower magnification (scale 
bar 10 µm) and (D) higher magnification (scale bar 4 µm). 
5.2.3 Drug release studies 
The drug release from the microparticles was characterized by a burst phase during the 
first 10-14 days, which was followed by slow release up to 60 days (Figure 16). This burst 
release is the consequence of the release of the loosely bound drug fraction and the portion 
of the drug located close to the particle surface.  
 
Figure 16 Drug release curves of indomethacin, metoprolol tartrate and verapamil 
hydrochloride loaded in the NFC microparticles. 
 
  Results and discussion 
 
 
 
34 
 
The drug release curves were fitted to a mathematical model describing the drug 
releasing kinetics from a spherical matrix (equation (2)) developed by Baker and Lonsdale 
[153]. The equation (2) can be modified as following: 
(4) 
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where Mt is the released drug amount at time t and M? is the amount of drug released at an 
infinitive time, the release constant k corresponds to the slope of the curves obtained when 
the left side of the equation is plotted against time. Linear fittings were obtained for all the 
analyzed batches indicating diffusion through the matrix system. 
Although this study confirmed the fact that NFC can be used as a material to sustain 
drug release, a more efficient production method was needed to overcome the yield and 
other manufacture problems of spray drying. 
5.3 Drug loaded NFC films for controlled drug release (III) 
5.3.1 Production of the films 
Method for the production of drug loaded NFC films was considered due to the existence 
of several drawbacks in the spray drying method used in the previous study (II). The 
proposed method is based on the property of NFC fibers to aggregate upon water removal 
from the material creating porous structures. This hornification phenomenon was 
discussed in the literature part of this thesis. In study (II) water removal was achieved by 
spray drying, while in study (III) this step was accomplished by a filtration method. 
During the filtration the NFC fibers collapse forming tight networks around the solid, 
water insoluble drug particles. Small amount of water that remained in the matrices after 
the filtration was removed during the following oven-drying step. In this way drug/NFC 
films with matrix structures were formed. The applied production method, besides 
simplicity, had an advantage of possible adjustments based on the desired product 
properties. Thus, by changing the concentration of drug/NFC mixture before filtration, 
matrices with different thicknesses and loadings could be fabricated. 
5.3.2 Characterization of the films 
The thickness of the produced films was in the range of 150-200 µm, which affected their 
mechanical properties. The NFC films produced from pure NFC with a thickness of 60 µm 
can be easily folded like conventional paper [99]. A greater thickness and presence of 
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incorporated solid materials lead to increased rigidity of the film, but their mechanical 
properties  still  allow  an  easy  bending  and  cutting  with  scissors.  When  it  comes  to  the  
morphology of the inner part, SEM imaging of the films cross-section revealed layered 
structures of the NFC fibers organized in lamellar phases entrapping and surrounding the 
solid drug (Figure 17).  
Solid state of the incorporated drugs was evaluated by thermal analysis (DSC), as well 
as by XRPD. It was concluded that the production method did not change the solid state of 
the drugs, and that their crystalline structure remained intact, which was expected 
considering the simplicity of the production method.  
 
Figure 17 Shematic drawing of the matrix structure of the films (middle), appearance of the film 
and dissolution profiles of beclomethasone dipropionate loaded films (left), SEM image of 
indomethacin loaded film before (up) and after (bottom) the dissolution studies  
5.3.2.1 Dissolution studies 
The specific target of the NFC films was to achieve sustained drug release profiles for 
long time periods, preferably for at least 3 months. The dissolution behavior was expected 
to be dependent on the penetration of the medium into the matrix structure and the 
diffusion of the drug through the tight fiber network. The long-lasting release was 
achieved from all the tested batches with differences in duration and rate of drug 
dissolution. The drug release did not affect the morphology of the films and their structure 
remained unchanged after the drug had been released (Figure 17). Beclomethasone 
dipropionate and itraconazole loaded matrices gave constant drug release profiles over the 
entire period of three months, with the release kinetics closest described with zero order 
kinetics (R2 > 0.986 for itraconazole and R2 > 0.982 for beclomethasone dipropionate 
films). However, the drug release curves for indomethacin had a different shape caused 
most likely by a different release mechanism (Figure 18).  
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Figure 18 Drug release curves of the indomethacin loaded NFC matrices. 
The films were flat and had a large aspect ratio. Hence, the release curves could be fitted 
to the model derived from the simple Higuchi equation [151]: 
(5) ? ? tCCDAM sst ???
? ?? 2       
where Mt is the amount of drug released, A is the surface area of the film, D is the 
diffusion coefficient of the drug inside the film, ? is the porosity of the film, ? is the 
tortuosity of the film, ? is the density of the drug material in the film, Cs is the saturated 
solubility of the drug inside the film and t is  time.  The  density  of  the  drug  in  the  above  
equation can be assumed to be:    
(6) INDf?? ?  
where f is the volume fraction of the drug in the film and ?IND is the density of solid 
indomethacin. Assuming that the drug has a low solubility in water, i.e. ? >>  Cs, the 
equation (5) reduces to: 
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where V is the volume and h is the half-thickness of the film. When the equation (7) was 
used to plot released fraction of drug against the square root of time, good correlation was 
obtained (Table 4). 
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Table 4. Fitting parameters for the theoretical release curves 
Loading 
(%) 
Slope 
(%/day) 
R2 
??? : 
????)IND20 
17.7 19.688 0.997 1.000 
27.7 16.725 0.996 1.231 
37.0 14.698 0.995 1.165 
    
It is obvious that there is difference in mechanism of drug release from matrices loaded 
with indomethacin, beclomethasone dipropionate, and itraconazole. The possible 
reasoning for the differences in the releasing mechanisms between the films with different 
incorporated drugs was found in the particle sizes of the incorporated drugs, where the 
dissolution of small evenly distributed particles causes an increased tortuosity of 
itraconazole matrices compared to the indomethacin films. Also pH of the medium used in 
the test could possibly cause slight changes in the NFC structure (due to the presence of 
xylan). Further reasons could be seen in the possible binding of the drug to the NFC fibers 
in a molecular form after it has dissolved from the drug particles. This could lead to 
desorption limited kinetics in the case of slow diffusion, which could cause the release to 
follow zero-order kinetic. However, at this point it was not possible to create a clear 
picture on the presence and influence of the binding. Hence, further investigations of the 
drug-NFC interactions were needed (see below).  
5.4 Drug interactions with the nanofibrillar cellulose (IV) 
5.4.1 Permeation studies 
There was an obvious need for the studies which would clarify the influence of factors 
affecting the drug release from the matrices. This knowledge could then also be used as a 
tool for drug screening when choosing suitable drug candidates for the NFC-containing 
drug formulations. Thus, we performed drug permeation tests through plain NFC films as 
a quick technique to estimate the rate of drug diffusion through a porous NFC network. 
Series of permeation tests at different pH-values were conducted using model compounds 
with different sizes. It was shown that the ability of NFC to slow down the drug diffusion 
was not changing significantly with small increases in the molecular size of the 
permeating compounds (Table 5). It was also concluded that the pH change of the used 
medium did not greatly change the membrane structure and, thus, did not influence the 
drug diffusion rate. 
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Table 5. Experimental conditions and the values of diffusion coefficients of compound 
permeation through the NFC films.  
Drug Medium Diffusion coefficient (cm2/s) 
Beclomethasone 
dipropionate 
1% HPBC 0.602x10-7 
1% HPBC/pH 1.2 0.601x10-7 
1% HPBC/pH 7.4 0.738x10-7 
Indomethacin 
MQ 2.128x10-7 
Phosphate buffer pH 5 1.710x10-7 
Phosphate buffer pH 7.4 2.540x10-7 
Itraconazole 0.03M NaCl/pH 1.2 1.548x10-7 
Nafarelin acetate MQ 1.541x10-7 
Lysozyme MQ 0.930x10-8 
5.4.2 Quantification of drug binding to NFC 
5.4.2.1 Incubation studies 
The  affinity  of  five  different  model  compounds  to  the  NFC  fibers  was  evaluated  by  
determination of the binding capacity. The bound amount was quantified by incubation of 
fiber suspension with a drug, followed by determination of the unbound fraction. It was 
found that the charge of the drugs and NFC (charge originating from the xylan residues in 
NFC) at the tested pH values (pH 3, pH 5.5, pH 7) plays an important role in the binding 
process. pKa of xylan is 3.7 [183], which means that it is mainly negatively charged at 
both pH-values of 5.5 and 7, thus, favoring the binding of positively charged molecules. 
The binding capacity is decreased at lower pH values (pH 3). Although the previous 
results showed that certain drugs show affinity and binding to the NFC, indicating 
electrostatic binding as the main mechanism, these studies did not provide information on 
the binding affinities. Hence, an ITC method was introduced to gain more quantitative 
information on the binding and the binding mechanisms. 
5.4.2.2 ITC studies 
The incubation studies above pointed out the electrostatic interactions between the 
xylan fraction in NFC and charged drugs as the main mechanism in the binding process. 
To evaluate the potential influence of charge to drug/NFC and drug/xylan interactions, and 
the corresponding enthalpic responses,  the ITC titrations were performed at  different pH 
values. Figure 19 shows a typical titration data of HFBI-DCBD binding to the NFC.  
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Figure 19 Typical titration data of HFBI-DCBD 
to NFC. Raw data (upper curve) - each heat flow 
peak corresponds to one injection of a HFBI-
DCBD. Titration isotherm (bottom curve) obtained 
by the integration of upper curve and subtraction of 
the dilution enthalpy. 
 
 
 
 
 
 
 
 
 
 
The results confirmed that the drugs bind to the NFC material and, again, indicated the 
pH dependence of the binding and electrostatic forces as the main mechanism (Table 6).  
 
Table 6.   Thermodynamic parameters (enthalpy ?H, entropy ?S, binding constant Kb, number of 
binding sites N) of the drug binding to NFC and xylan. Titrations for which the pH value is not 
noted were performed using aqueous solutions/dispersions without adjusting the pH. The 
abbreviations LYS, NAF and XYL state for lysozyme, nafarelin acetate and xylan respectively. 
Titration 
Binding 
capacity 
(µmol/g) 
Kb(M-1)  ?H (Jmol-1)  ?S (Jmol-1deg-1) a)N (sites) 
LYS to NFC 1.48 3.99×106 -8.59×104 -162 3.85×103 
LYS to NFC pH3 0.46 9.16×106 -4.65×104 -22.6 2.17×104 
LYS to XYL  16.91 1.41×107 -4.38×104 -10.1 3.12×102 
LYS to XYL pH3 4.82 3.37×107 -6.78×104 -83.1 1.30×103 
HFBI-DCBD to NFC 3.48 1.63×106 -1.84×105 -499 2.44×103 
HFBI to NFC 2.62 1.92×106 -5.97×104 -79.9 3.03×103 
NAF to XYL 69.44 1.10×106 -1.58×105 -413.0 3.57×103 
a) Number of binding sites calculated as number of glucose or xylose units needed for binding of 
one drug molecule 
However it is not completely clear, whether electrostatic binding is the only 
mechanism involved. It has been well known that aromatic residues play an important role 
in the binding of proteins to the crystalline part of cellulose via an interaction of three 
tyrosine residues organized in a planar surface and glucopyranose units of cellulose chains 
supported by hydrogen bonds [184, 185]. Lysozyme protein molecules are rich in 
 
  Results and discussion 
 
 
 
40 
 
aromatic amino acids (3 tyrosine, 6 tryptophan, and 3 phenylalanine residues out of 129 
residues in total) [186], and nafarelin acetate also possesses the aromatic rings [187] which 
could potentially interact with cellulose. Therefore, the possibility that lysozyme binds not 
only to xylan part via electrostatic interactions, but also to cellulose chains via ? stacking 
and hydrogen bonding, should not be excluded. 
As a conclusion, the study provided deeper knowledge on the processes and 
mechanisms occurring when NFC is used as drug release controlling material.  
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6 Conclusions 
Nanofibrillar cellulose (NFC) of wood (birch) origin was tested as a novel 
pharmaceutical excipient. Standard methods for tablet production were used to evaluate 
the applicability of spray dried NFC as filler for tablet manufacturing. The spray dried 
NFC powder was characterized in terms of particle size and morphology, density, and 
flowability. The addition of NFC to commercially used microcrystalline cellulose (MCC) 
improved its flow properties. Tablets made of NFC were successfully prepared either by 
direct compression method or compression after wet granulation. Compared to MCC, 
NFC was found to deform less plastically and have more pronounced brittle 
characteristics. NFC did not affect the drug release from the tablets manufactured with 
active model compounds.  
Spray drying process was developed to produce drug loaded NFC microparticles for 
longer-lasting controlled drug release. NFC fibers formed network structures during the 
drying process entrapping the drug within the microparticles. The formed network was 
tight  enough to  sustain  the  release  of  the  drug  for  up  to  two months.  The  results  of  this  
study indicated the capability of NFC fibers to sustain the relase of a drug. However, the 
spray drying process suffered from drawbacks, such as limitation to water soluble 
compounds, low loadings due to the different drying kinetics of drug and NFC, thus 
warranting the need for better manufacturing process to overcome the mentioned 
problems.  
An easy three step method for the production of drug loaded NFC films was 
introduced for this purpose. The method resulted in highly loaded (20% – 40%) NFC films 
with excellent mechanical properties, which provided easy handling and shape and size 
adjustment. The films had matrix structures with NFC fibers as a matrix former, and 
uniformly dispersed drugs in crystalline form. The systems gave controlled drug release 
profiles for a period of over three months,  which for some drugs was very close to zero 
order  drug  release  kinetics.  The  systems  completely  retained  their  shapes  after  the  drug  
had been released. This work clearly confrimed the applicability of NFC as drug delivery 
reate controlling material. 
More in depth interactions between the NFC fibers and a range of model compounds 
were also studied. It was found out that the main mechanism of interaction lies in the 
binding of positively charged drugs to the negatively charged xylan fraction of the NFC 
material via electrostatic interactions.  
As  a  summary,  this  thesis  represents  the  very  first  steps  on  a  way  to  explore  the  
potential multiple applications of NFC in the manufacture and formulation of 
pharmaceutical dosage forms and further work is needed to advance its utilization in drug 
delivery systems.  
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